Table 2

Early and Late Outcomes

TEVAR
(n = 184)
BMT
(n = 154)
p Value
Hospital stay, days11.10 ± 4.6612.35 ± 3.410.003
Early events19 (10.3)7 (4.5)0.064
Minor complication<0.001
 Became complicated0 (0.0)3 (1.9)
 Type I endoleak17 (9.2)NA
Major complication0.17
 Organ failure1 (0.5)1 (0.6)
 Stroke1 (0.5)0 (0.0)
 Rupture0 (0.0)3 (1.9)
30-day death1 (0.5)4 (2.6)0.18
Follow-up time, months
 CTA follow-up28.5 ± 40.238.6 ± 39.20.40
 Survival follow-up29.9 ± 41.739.5 ± 39.90.56
Late events44 (23.9)59 (38.3)0.005
 Type I endoleak11 (6.0)NA
 Rupture6 (3.3)19 (12.3)
 Retrograde type A-AD4 (2.2)9 (5.8)
 Aortic enlargement14 (7.6)28 (18.2)
 Ulcer-like projection0 (0.0)3 (1.9)
 Proximal SINE2 (1.1)NA
 Distal SINE7 (3.8)NA
Late death0.030
 Aortic related8 (4.3)19 (12.3)
 Aortic unrelated8 (4.3)10 (6.5)
 Unknown3 (1.6)2 (1.3)

Values are mean ± SD or n (%).

A-AD = type A aortic dissection; CTA = computed tomography angiography; SINE = stent graft-induced new entry; other abbreviations as in Table 1.